id stringlengths 15 15 | document_id stringlengths 11 11 | passages list | entities list | events list | coreferences list | relations list |
|---|---|---|---|---|---|---|
NCT00050349_exc | NCT00050349 | [
{
"id": "NCT00050349_exc_text",
"type": "exclusion",
"text": [
"Patients with symptomatic CNS metastases or leptomeningeal involvement \nPatients with known brain metastases, unless these metastases have been treated and/or have been stable for at least six months prior to study start. Subjects wi... | [
{
"id": "NCT00050349_exc_T1",
"type": "Condition",
"text": [
"CNS metastases"
],
"offsets": [
[
26,
40
]
],
"normalized": []
},
{
"id": "NCT00050349_exc_T2",
"type": "Condition",
"text": [
"leptomeningeal involvement"
],
"of... | [] | [] | [
{
"id": "NCT00050349_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00050349_exc_T6",
"arg2_id": "NCT00050349_exc_T7",
"normalized": []
},
{
"id": "NCT00050349_exc_R3",
"type": "AND",
"arg1_id": "NCT00050349_exc_T8",
"arg2_id": "NCT00050349_exc_T9",
"normalized": []
},... |
NCT00050349_inc | NCT00050349 | [
{
"id": "NCT00050349_inc_text",
"type": "inclusion",
"text": [
"Patients with biopsy-proven metastatic carcinoid tumors or other neuroendocrine tumors (Islet cell, Gastrinomas and VIPomas) with at least one measurable lesion (other than bone) that has either not been previously irradiated or if pr... | [
{
"id": "NCT00050349_inc_T1",
"type": "Condition",
"text": [
"metastatic carcinoid tumors"
],
"offsets": [
[
28,
55
]
],
"normalized": []
},
{
"id": "NCT00050349_inc_T2",
"type": "Value",
"text": [
"proven"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00050349_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00050349_inc_T3",
"arg2_id": "NCT00050349_inc_T2",
"normalized": []
},
{
"id": "NCT00050349_inc_R2",
"type": "AND",
"arg1_id": "NCT00050349_inc_T1",
"arg2_id": "NCT00050349_inc_T3",
"normalized": []
},
... |
NCT00061308_exc | NCT00061308 | [
{
"id": "NCT00061308_exc_text",
"type": "exclusion",
"text": [
"Women of child-bearing potential that do not practice adequate contraception. \nPregnant or lactating. \nReceived more than one primary chemotherapy regimen. \nConcomitant or previous malignancies with the exception of adequately trea... | [
{
"id": "NCT00061308_exc_T1",
"type": "Person",
"text": [
"Women"
],
"offsets": [
[
0,
5
]
],
"normalized": []
},
{
"id": "NCT00061308_exc_T2",
"type": "Condition",
"text": [
"child-bearing potential"
],
"offsets": [
[... | [] | [] | [
{
"id": "NCT00061308_exc_R1",
"type": "Has_negation",
"arg1_id": "NCT00061308_exc_T4",
"arg2_id": "NCT00061308_exc_T3",
"normalized": []
},
{
"id": "NCT00061308_exc_R2",
"type": "AND",
"arg1_id": "NCT00061308_exc_T2",
"arg2_id": "NCT00061308_exc_T4",
"normalized": []
},... |
NCT00061308_inc | NCT00061308 | [
{
"id": "NCT00061308_inc_text",
"type": "inclusion",
"text": [
"Have had one prior platinum-based chemotherapy regimen for the treatment of primary disease. \nAt least 4 weeks since last surgery or radiation therapy. \nMust have had a treatment-free interval of greater than 6 months following resp... | [
{
"id": "NCT00061308_inc_T1",
"type": "Drug",
"text": [
"platinum-based chemotherapy regimen"
],
"offsets": [
[
19,
54
]
],
"normalized": []
},
{
"id": "NCT00061308_inc_T2",
"type": "Condition",
"text": [
"primary disease"
],
... | [] | [] | [
{
"id": "NCT00061308_inc_R1",
"type": "AND",
"arg1_id": "NCT00061308_inc_T2",
"arg2_id": "NCT00061308_inc_T1",
"normalized": []
},
{
"id": "NCT00061308_inc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00061308_inc_T1",
"arg2_id": "NCT00061308_inc_T3",
"normalized": []
},... |
NCT00094861_exc | NCT00094861 | [
{
"id": "NCT00094861_exc_text",
"type": "exclusion",
"text": [
"Metastatic disease (M1)/stage 4 NSCLC \nPleural or pericardial effusion greater than 100 ml in volume as documented by appropriate imaging (positron emission tomography [PET], computed tomography [CT] scan or ultrasound). If an effusi... | [
{
"id": "NCT00094861_exc_T1",
"type": "Condition",
"text": [
"Metastatic disease",
"NSCLC"
],
"offsets": [
[
0,
18
],
[
32,
37
]
],
"normalized": []
},
{
"id": "NCT00094861_exc_T2",
"type": "Condition",
"... | [] | [] | [
{
"id": "NCT00094861_exc_R1",
"type": "Subsumes",
"arg1_id": "NCT00094861_exc_T1",
"arg2_id": "NCT00094861_exc_T2",
"normalized": []
},
{
"id": "NCT00094861_exc_R2",
"type": "Subsumes",
"arg1_id": "NCT00094861_exc_T6",
"arg2_id": "NCT00094861_exc_T8",
"normalized": []
}... |
NCT00094861_inc | NCT00094861 | [
{
"id": "NCT00094861_inc_text",
"type": "inclusion",
"text": [
"Patients with a histologically or cytologically proven diagnosis of NSCLC \nUnresectable (locally advanced) stage IIIa or IIIb disease \nInitial radiotherapy field of treatment to encompass greater than or equal to 30% of the esophagu... | [
{
"id": "NCT00094861_inc_T1",
"type": "Condition",
"text": [
"NSCLC"
],
"offsets": [
[
68,
73
]
],
"normalized": []
},
{
"id": "NCT00094861_inc_T2",
"type": "Qualifier",
"text": [
"cytologically proven"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00094861_inc_R1",
"type": "Has_scope",
"arg1_id": "NCT00094861_inc_T1",
"arg2_id": "NCT00094861_inc_T4",
"normalized": []
},
{
"id": "NCT00094861_inc_R2",
"type": "Subsumes",
"arg1_id": "NCT00094861_inc_T7",
"arg2_id": "NCT00094861_inc_T8",
"normalized": []
... |
NCT00122070_exc | NCT00122070 | [
{
"id": "NCT00122070_exc_text",
"type": "exclusion",
"text": [
"Are pregnant or lactating. \nHave participated in any other studies involving investigational products within 30 days prior to entry into this study. \nAre undergoing an acute withdrawal syndrome from drugs or alcohol. \nHave an Axis ... | [
{
"id": "NCT00122070_exc_T1",
"type": "Condition",
"text": [
"pregnant"
],
"offsets": [
[
4,
12
]
],
"normalized": []
},
{
"id": "NCT00122070_exc_T2",
"type": "Condition",
"text": [
"lactating"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00122070_exc_R1",
"type": "Has_index",
"arg1_id": "NCT00122070_exc_T4",
"arg2_id": "NCT00122070_exc_T5",
"normalized": []
},
{
"id": "NCT00122070_exc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00122070_exc_T3",
"arg2_id": "NCT00122070_exc_T4",
"normalized": [... |
NCT00122070_inc | NCT00122070 | [
{
"id": "NCT00122070_inc_text",
"type": "inclusion",
"text": [
"Provide written informed consent before beginning any study related activities \nBe between age 18 and 55 years \nBe able to speak, read and write English and follow simple instructions for completing self-rated scales \nMeet DSM-IV c... | [
{
"id": "NCT00122070_inc_T2",
"type": "Person",
"text": [
"age"
],
"offsets": [
[
91,
94
]
],
"normalized": []
},
{
"id": "NCT00122070_inc_T3",
"type": "Value",
"text": [
"between",
"18 and 55 years"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00122070_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00122070_inc_T2",
"arg2_id": "NCT00122070_inc_T3",
"normalized": []
},
{
"id": "NCT00122070_inc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00122070_inc_T5",
"arg2_id": "NCT00122070_inc_T6",
"normalized": ... |
NCT00182520_exc | NCT00182520 | [
{
"id": "NCT00182520_exc_text",
"type": "exclusion",
"text": [
"Any other primary DSM-IV diagnosis; DSM-IV criteria for body dysmorphic disorder, bipolar affective disorder, schizophrenia, psychotic disorder, current alcohol/substance abuse.\nA previous adequate trial of topiramate\nComorbid major... | [
{
"id": "NCT00182520_exc_T1",
"type": "Qualifier",
"text": [
"DSM-IV"
],
"offsets": [
[
18,
24
]
],
"normalized": []
},
{
"id": "NCT00182520_exc_T2",
"type": "Qualifier",
"text": [
"primary"
],
"offsets": [
[
1... | [] | [] | [
{
"id": "NCT00182520_exc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00182520_exc_T3",
"arg2_id": "NCT00182520_exc_T1",
"normalized": []
},
{
"id": "NCT00182520_exc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00182520_exc_T3",
"arg2_id": "NCT00182520_exc_T2",
"normalize... |
NCT00182520_inc | NCT00182520 | [
{
"id": "NCT00182520_inc_text",
"type": "inclusion",
"text": [
"Outpatient with primary DSM- IV OCD\nCompletion of a 14-week open label trial of one the following SRI's: fluoxetine 80 mg/day, paroxetine 60 mg/day, fluvoxamine 300 mg/day, clomipramine 250 mg/day, sertraline 200 mg/day, citalopram 6... | [
{
"id": "NCT00182520_inc_T1",
"type": "Condition",
"text": [
"OCD"
],
"offsets": [
[
32,
35
]
],
"normalized": []
},
{
"id": "NCT00182520_inc_T2",
"type": "Qualifier",
"text": [
"primary"
],
"offsets": [
[
16,
... | [] | [] | [
{
"id": "NCT00182520_inc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00182520_inc_T1",
"arg2_id": "NCT00182520_inc_T3",
"normalized": []
},
{
"id": "NCT00182520_inc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00182520_inc_T1",
"arg2_id": "NCT00182520_inc_T2",
"normalize... |
NCT00183885_exc | NCT00183885 | [
{
"id": "NCT00183885_exc_text",
"type": "exclusion",
"text": [
"Patients who have received prior chemotherapy for unresectable disease \nPatients with any active or uncontrolled infection, including known HIV infection. (Patients with active hepatitis B will be placed on lamivudine. Patients with ... | [
{
"id": "NCT00183885_exc_T1",
"type": "Procedure",
"text": [
"chemotherapy"
],
"offsets": [
[
33,
45
]
],
"normalized": []
},
{
"id": "NCT00183885_exc_T2",
"type": "Condition",
"text": [
"unresectable disease"
],
"offsets": ... | [] | [] | [
{
"id": "NCT00183885_exc_R1",
"type": "AND",
"arg1_id": "NCT00183885_exc_T1",
"arg2_id": "NCT00183885_exc_T2",
"normalized": []
},
{
"id": "NCT00183885_exc_R2",
"type": "Has_scope",
"arg1_id": "NCT00183885_exc_T5",
"arg2_id": "NCT00183885_exc_T6",
"normalized": []
},
... |
NCT00183885_inc | NCT00183885 | [
{
"id": "NCT00183885_inc_text",
"type": "inclusion",
"text": [
"Unresectable, histologically confirmed hepatocellular carcinoma with evident disease limited to liver. \nTissue from tumor must be available. This may be paraffin embedded tissue from previous biopsy/resection or if it is not availabl... | [
{
"id": "NCT00183885_inc_T1",
"type": "Qualifier",
"text": [
"Unresectable"
],
"offsets": [
[
0,
12
]
],
"normalized": []
},
{
"id": "NCT00183885_inc_T2",
"type": "Condition",
"text": [
"hepatocellular carcinoma"
],
"offsets... | [] | [] | [
{
"id": "NCT00183885_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00183885_inc_T3",
"arg2_id": "NCT00183885_inc_T4",
"normalized": []
},
{
"id": "NCT00183885_inc_R2",
"type": "AND",
"arg1_id": "NCT00183885_inc_T2",
"arg2_id": "NCT00183885_inc_T3",
"normalized": []
},
... |
NCT00198913_exc | NCT00198913 | [
{
"id": "NCT00198913_exc_text",
"type": "exclusion",
"text": [
"type 1 diabetic or non-diabetic \n \n"
],
"offsets": [
[
0,
44
]
]
}
] | [
{
"id": "NCT00198913_exc_T1",
"type": "Condition",
"text": [
"type 1 diabetic"
],
"offsets": [
[
0,
15
]
],
"normalized": []
},
{
"id": "NCT00198913_exc_T2",
"type": "Condition",
"text": [
"non-diabetic"
],
"offsets": [
... | [] | [] | [] |
NCT00198913_inc | NCT00198913 | [
{
"id": "NCT00198913_inc_text",
"type": "inclusion",
"text": [
"type 2 diabetic, age 18 and over, informed consent, \n"
],
"offsets": [
[
0,
53
]
]
}
] | [
{
"id": "NCT00198913_inc_T1",
"type": "Condition",
"text": [
"type 2 diabetic"
],
"offsets": [
[
0,
15
]
],
"normalized": []
},
{
"id": "NCT00198913_inc_T2",
"type": "Person",
"text": [
"age"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00198913_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00198913_inc_T2",
"arg2_id": "NCT00198913_inc_T3",
"normalized": []
}
] |
NCT00235170_exc | NCT00235170 | [
{
"id": "NCT00235170_exc_text",
"type": "exclusion",
"text": [
"1. Congestive heart failure; \n2. CABG or Percutaneous Coronary Intervention (PCI) procedure; \n3. Planned need for major surgery (e.g. valve surgery or resection of aortic or left ventricular aneurysm, carotid end-arterectomy, abdomi... | [
{
"id": "NCT00235170_exc_T1",
"type": "Condition",
"text": [
"Congestive heart failure"
],
"offsets": [
[
3,
27
]
],
"normalized": []
},
{
"id": "NCT00235170_exc_T2",
"type": "Procedure",
"text": [
"CABG"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00235170_exc_R1",
"type": "Has_negation",
"arg1_id": "NCT00235170_exc_T15",
"arg2_id": "NCT00235170_exc_T14",
"normalized": []
},
{
"id": "NCT00235170_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00235170_exc_T13",
"arg2_id": "NCT00235170_exc_T15",
"normalized... |
NCT00235170_inc | NCT00235170 | [
{
"id": "NCT00235170_inc_text",
"type": "inclusion",
"text": [
"1. Patients with stable (Canadian Cardiovascular Society 1, 2, 3 or 4) or unstable (Braunwald class IB, IC, IIB, IIC, IIIB, IIIC) angina pectoris and ischemia, or patients with atypical chest pain or even those who are asymptomatic pr... | [
{
"id": "NCT00235170_inc_T1",
"type": "Measurement",
"text": [
"Canadian Cardiovascular Society"
],
"offsets": [
[
25,
56
]
],
"normalized": []
},
{
"id": "NCT00235170_inc_T2",
"type": "Value",
"text": [
"1, 2, 3 or 4"
],
"o... | [] | [] | [
{
"id": "NCT00235170_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00235170_inc_T1",
"arg2_id": "NCT00235170_inc_T2",
"normalized": []
},
{
"id": "NCT00235170_inc_R2",
"type": "Subsumes",
"arg1_id": "NCT00235170_inc_T3",
"arg2_id": "NCT00235170_inc_T1",
"normalized": []
... |
NCT00236340_exc | NCT00236340 | [
{
"id": "NCT00236340_exc_text",
"type": "exclusion",
"text": [
"Multiple pregnancy (more than 3 fetuses) \nMaternal history of placental abruptio \nFetus with IUGR \nPregnancy complicated with pre-eclampsia \nUnability to give informed consent \n \n"
],
"offsets": [
[
... | [
{
"id": "NCT00236340_exc_T1",
"type": "Condition",
"text": [
"Multiple pregnancy"
],
"offsets": [
[
0,
18
]
],
"normalized": []
},
{
"id": "NCT00236340_exc_T2",
"type": "Value",
"text": [
"more than 3"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00236340_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00236340_exc_T3",
"arg2_id": "NCT00236340_exc_T2",
"normalized": []
},
{
"id": "NCT00236340_exc_R3",
"type": "AND",
"arg1_id": "NCT00236340_exc_T5",
"arg2_id": "NCT00236340_exc_T4",
"normalized": []
},
... |
NCT00236340_inc | NCT00236340 | [
{
"id": "NCT00236340_inc_text",
"type": "inclusion",
"text": [
"Pregnant women with abdomen discumfort and ultrasound diagnosis of polyhydramnios (AFI>25cm) \nSingle or twin pregnancies \n"
],
"offsets": [
[
0,
122
]
]
}
] | [
{
"id": "NCT00236340_inc_T1",
"type": "Condition",
"text": [
"Pregnant"
],
"offsets": [
[
0,
8
]
],
"normalized": []
},
{
"id": "NCT00236340_inc_T2",
"type": "Person",
"text": [
"women"
],
"offsets": [
[
9,
... | [] | [] | [
{
"id": "NCT00236340_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00236340_inc_T6",
"arg2_id": "NCT00236340_inc_T7",
"normalized": []
},
{
"id": "NCT00236340_inc_R3",
"type": "Has_value",
"arg1_id": "NCT00236340_inc_T4",
"arg2_id": "NCT00236340_inc_T8",
"normalized": []
... |
NCT00250640_exc | NCT00250640 | [
{
"id": "NCT00250640_exc_text",
"type": "exclusion",
"text": [
"Any condition that prevents participation in the study, including pregnancy and other contraindications for Ventavis treatment (as listed in the current Ventavis Summary of Product Characteristics and patient package insert) \n ... | [
{
"id": "NCT00250640_exc_T1",
"type": "Condition",
"text": [
"pregnancy"
],
"offsets": [
[
66,
75
]
],
"normalized": []
},
{
"id": "NCT00250640_exc_T2",
"type": "Condition",
"text": [
"contraindications"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00250640_exc_R1",
"type": "AND",
"arg1_id": "NCT00250640_exc_T2",
"arg2_id": "NCT00250640_exc_T3",
"normalized": []
},
{
"id": "NCT00250640_exc_R2",
"type": "Subsumes",
"arg1_id": "NCT00250640_exc_T2",
"arg2_id": "NCT00250640_exc_T4",
"normalized": []
}
] |
NCT00250640_inc | NCT00250640 | [
{
"id": "NCT00250640_inc_text",
"type": "inclusion",
"text": [
"The treating physician has chosen Ventavis as a suitable long-term treatment for the patient \nPatient with primary pulmonary hypertension (i.e. Idiopathic Pulmonary Arterial Hypertension or Familial Pulmonary Arterial Hypertension) a... | [
{
"id": "NCT00250640_inc_T1",
"type": "Drug",
"text": [
"Ventavis"
],
"offsets": [
[
34,
42
]
],
"normalized": []
},
{
"id": "NCT00250640_inc_T2",
"type": "Condition",
"text": [
"primary pulmonary hypertension"
],
"offsets":... | [] | [] | [
{
"id": "NCT00250640_inc_R1",
"type": "Subsumes",
"arg1_id": "NCT00250640_inc_T2",
"arg2_id": "NCT00250640_inc_T5",
"normalized": []
},
{
"id": "NCT00250640_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00250640_inc_T6",
"arg2_id": "NCT00250640_inc_T7",
"normalized": []
... |
NCT00279552_exc | NCT00279552 | [
{
"id": "NCT00279552_exc_text",
"type": "exclusion",
"text": [
"Patients who were pregnant, nursing or not able to give written informed consent were excluded. \n \n"
],
"offsets": [
[
0,
108
]
]
}
] | [
{
"id": "NCT00279552_exc_T1",
"type": "Condition",
"text": [
"pregnant"
],
"offsets": [
[
18,
26
]
],
"normalized": []
},
{
"id": "NCT00279552_exc_T2",
"type": "Condition",
"text": [
"nursing"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00279552_exc_R1",
"type": "Has_negation",
"arg1_id": "NCT00279552_exc_T3",
"arg2_id": "NCT00279552_exc_T4",
"normalized": []
}
] |
NCT00279552_inc | NCT00279552 | [
{
"id": "NCT00279552_inc_text",
"type": "inclusion",
"text": [
"Patients suspected to have vitamin B12 deficiency defined as a plasma vitamin B12 below the reference interval (<200 pmol/L). \n"
],
"offsets": [
[
0,
127
]
]
}
] | [
{
"id": "NCT00279552_inc_T1",
"type": "Condition",
"text": [
"vitamin B12 deficiency"
],
"offsets": [
[
27,
49
]
],
"normalized": []
},
{
"id": "NCT00279552_inc_T2",
"type": "Mood",
"text": [
"suspected"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00279552_inc_R1",
"type": "Has_mood",
"arg1_id": "NCT00279552_inc_T1",
"arg2_id": "NCT00279552_inc_T2",
"normalized": []
},
{
"id": "NCT00279552_inc_R2",
"type": "Subsumes",
"arg1_id": "NCT00279552_inc_T4",
"arg2_id": "NCT00279552_inc_T5",
"normalized": []
}... |
NCT00305097_exc | NCT00305097 | [
{
"id": "NCT00305097_exc_text",
"type": "exclusion",
"text": [
"Any condition/illness that may affect the study outcomes or would make participation potentially harmful such as pregnancy or breastfeeding, diabetes mellitus, heart disease, stroke, hypertension, malabsorption syndromes, GERD, a hist... | [
{
"id": "NCT00305097_exc_T1",
"type": "Condition",
"text": [
"pregnancy"
],
"offsets": [
[
113,
122
]
],
"normalized": []
},
{
"id": "NCT00305097_exc_T2",
"type": "Observation",
"text": [
"breastfeeding"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00305097_exc_R1",
"type": "AND",
"arg1_id": "NCT00305097_exc_T9",
"arg2_id": "NCT00305097_exc_T10",
"normalized": []
},
{
"id": "NCT00305097_exc_R2",
"type": "Subsumes",
"arg1_id": "NCT00305097_exc_T14",
"arg2_id": "NCT00305097_exc_T13",
"normalized": []
},
... |
NCT00305097_inc | NCT00305097 | [
{
"id": "NCT00305097_inc_text",
"type": "inclusion",
"text": [
"Aged at least 18 years with an ability and willingness to give written informed consent. \nBody mass index 25-35 kg/m2 \nUsers of at least 2 cups of caffeinated coffee per day who are willing to be randomized to any of the interventio... | [
{
"id": "NCT00305097_inc_T1",
"type": "Person",
"text": [
"Aged"
],
"offsets": [
[
0,
4
]
],
"normalized": []
},
{
"id": "NCT00305097_inc_T2",
"type": "Value",
"text": [
"at least 18 years"
],
"offsets": [
[
5,... | [] | [] | [
{
"id": "NCT00305097_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00305097_inc_T1",
"arg2_id": "NCT00305097_inc_T2",
"normalized": []
},
{
"id": "NCT00305097_inc_R2",
"type": "Has_multiplier",
"arg1_id": "NCT00305097_inc_T8",
"arg2_id": "NCT00305097_inc_T7",
"normalized":... |
NCT00312429_exc | NCT00312429 | [
{
"id": "NCT00312429_exc_text",
"type": "exclusion",
"text": [
"Undergoing Interleukin-2 (IL-2) therapy within 8 weeks of study entry \nDiagnosed with a medical or psychiatric illness that may interfere with study participation \nPregnant \n \n"
],
"offsets": [
[
0,
... | [
{
"id": "NCT00312429_exc_T1",
"type": "Procedure",
"text": [
"Interleukin-2 (IL-2) therapy"
],
"offsets": [
[
11,
39
]
],
"normalized": []
},
{
"id": "NCT00312429_exc_T2",
"type": "Temporal",
"text": [
"within 8 weeks of study entry... | [] | [] | [
{
"id": "NCT00312429_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00312429_exc_T1",
"arg2_id": "NCT00312429_exc_T2",
"normalized": []
}
] |
NCT00312429_inc | NCT00312429 | [
{
"id": "NCT00312429_inc_text",
"type": "inclusion",
"text": [
"Diagnosis reviewed at transplant center and confirmed to fit the criterion for high risk blood disease or cancer, as defined for the study \nEstimated life expectancy of at least 6 weeks following study entry \nCancer and Leukemia Gro... | [
{
"id": "NCT00312429_inc_T1",
"type": "Condition",
"text": [
"high risk blood disease"
],
"offsets": [
[
79,
102
]
],
"normalized": []
},
{
"id": "NCT00312429_inc_T2",
"type": "Condition",
"text": [
"cancer"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00312429_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00312429_inc_T3",
"arg2_id": "NCT00312429_inc_T4",
"normalized": []
},
{
"id": "NCT00312429_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00312429_inc_T5",
"arg2_id": "NCT00312429_inc_T8",
"normalized": []
... |
NCT00317148_exc | NCT00317148 | [
{
"id": "NCT00317148_exc_text",
"type": "exclusion",
"text": [
"Body mass index (BMI) of 35 kg/m2 or more. \nSignificant metabolic and endocrine diseases. \nDiagnosis of cancer. \nUse of steroids or drugs that interfere with the metabolism of estrogen. \nUse of any systemic estrogen, progestin, or... | [
{
"id": "NCT00317148_exc_T1",
"type": "Measurement",
"text": [
"Body mass index (BMI)"
],
"offsets": [
[
0,
21
]
],
"normalized": []
},
{
"id": "NCT00317148_exc_T2",
"type": "Value",
"text": [
"35 kg/m2 or more"
],
"offsets"... | [] | [] | [
{
"id": "NCT00317148_exc_R1",
"type": "Has_value",
"arg1_id": "NCT00317148_exc_T1",
"arg2_id": "NCT00317148_exc_T2",
"normalized": []
},
{
"id": "NCT00317148_exc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00317148_exc_T12",
"arg2_id": "NCT00317148_exc_T11",
"normalized":... |
NCT00317148_inc | NCT00317148 | [
{
"id": "NCT00317148_inc_text",
"type": "inclusion",
"text": [
"Healthy postmenopausal women with 50 or more moderate to severe hot flushes. \nWomen between 40 to 70 years of age. \n"
],
"offsets": [
[
0,
116
]
]
}
] | [
{
"id": "NCT00317148_inc_T1",
"type": "Condition",
"text": [
"postmenopausal"
],
"offsets": [
[
8,
22
]
],
"normalized": []
},
{
"id": "NCT00317148_inc_T2",
"type": "Condition",
"text": [
"Healthy"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00317148_inc_R1",
"type": "AND",
"arg1_id": "NCT00317148_inc_T4",
"arg2_id": "NCT00317148_inc_T5",
"normalized": []
},
{
"id": "NCT00317148_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00317148_inc_T8",
"arg2_id": "NCT00317148_inc_T7",
"normalized": []
}
] |
NCT00319748_exc | NCT00319748 | [
{
"id": "NCT00319748_exc_text",
"type": "exclusion",
"text": [
"Had/have the following prior/concurrent therapy: \nSystemic corticosteroids (oral or injectable) within 7 days of first dose of 852A (topical or inhaled steroids are allowed) \nInvestigational drugs/agents within 14 days of first dose... | [
{
"id": "NCT00319748_exc_T1",
"type": "Drug",
"text": [
"Systemic corticosteroids"
],
"offsets": [
[
50,
74
]
],
"normalized": []
},
{
"id": "NCT00319748_exc_T2",
"type": "Temporal",
"text": [
"within 7 days of first dose"
],
... | [] | [] | [
{
"id": "NCT00319748_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00319748_exc_T1",
"arg2_id": "NCT00319748_exc_T2",
"normalized": []
},
{
"id": "NCT00319748_exc_R2",
"type": "AND",
"arg1_id": "NCT00319748_exc_T2",
"arg2_id": "NCT00319748_exc_T3",
"normalized": []
},... |
NCT00319748_inc | NCT00319748 | [
{
"id": "NCT00319748_inc_text",
"type": "inclusion",
"text": [
"Adequate performance status: \nBreast - Karnofsky score > 50; \nOvarian, endometrial or cervical - Gynecologic Oncology Group (GOG) performance score ≤2 \nIf female and of childbearing potential, are willing to use adequate contracept... | [
{
"id": "NCT00319748_inc_T1",
"type": "Measurement",
"text": [
"Breast - Karnofsky score"
],
"offsets": [
[
30,
54
]
],
"normalized": []
},
{
"id": "NCT00319748_inc_T2",
"type": "Value",
"text": [
"> 50"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00319748_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00319748_inc_T1",
"arg2_id": "NCT00319748_inc_T2",
"normalized": []
},
{
"id": "NCT00319748_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00319748_inc_T3",
"arg2_id": "NCT00319748_inc_T4",
"normalized": []
... |
NCT00324363_exc | NCT00324363 | [
{
"id": "NCT00324363_exc_text",
"type": "exclusion",
"text": [
"Have participated in this study previously, or any other study using exenatide or GLP-1 analogs. \nHave participated in an interventional, medical, surgical, or pharmaceutical study within 30 days of screening. \nHave characteristics ... | [
{
"id": "NCT00324363_exc_T1",
"type": "Drug",
"text": [
"GLP-1 analogs"
],
"offsets": [
[
82,
95
]
],
"normalized": []
},
{
"id": "NCT00324363_exc_T2",
"type": "Observation",
"text": [
"this study"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00324363_exc_R4",
"type": "Has_temporal",
"arg1_id": "NCT00324363_exc_T12",
"arg2_id": "NCT00324363_exc_T11",
"normalized": []
},
{
"id": "NCT00324363_exc_R6",
"type": "Has_scope",
"arg1_id": "NCT00324363_exc_T16",
"arg2_id": "NCT00324363_exc_T17",
"normalized... |
NCT00324363_inc | NCT00324363 | [
{
"id": "NCT00324363_inc_text",
"type": "inclusion",
"text": [
"Treated with a stable dose of one of the following for at least 3 months prior to screening: * >=1000 mg/day immediate-release metformin; or metformin >=1000 mg/day and sulfonylurea; or sulfonylurea/metformin combination therapy. \nHb... | [
{
"id": "NCT00324363_inc_T1",
"type": "Qualifier",
"text": [
"stable dose"
],
"offsets": [
[
15,
26
]
],
"normalized": []
},
{
"id": "NCT00324363_inc_T2",
"type": "Temporal",
"text": [
"at least 3 months prior to screening"
],
... | [] | [] | [
{
"id": "NCT00324363_inc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00324363_inc_T1",
"arg2_id": "NCT00324363_inc_T2",
"normalized": []
},
{
"id": "NCT00324363_inc_R2",
"type": "AND",
"arg1_id": "NCT00324363_inc_T6",
"arg2_id": "NCT00324363_inc_T5",
"normalized": []
},... |
NCT00343668_exc | NCT00343668 | [
{
"id": "NCT00343668_exc_text",
"type": "exclusion",
"text": [
"Other tumor type than adenocarcinoma \nCentral nervous system (CNS) metastases or prior radiation for CNS metastases \nGastric outlet obstruction or intestinal obstruction \nEvidence of gastrointestinal bleeding \nThe patient has bony... | [
{
"id": "NCT00343668_exc_T1",
"type": "Condition",
"text": [
"adenocarcinoma"
],
"offsets": [
[
22,
36
]
],
"normalized": []
},
{
"id": "NCT00343668_exc_T2",
"type": "Condition",
"text": [
"tumor"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00343668_exc_R2",
"type": "AND",
"arg1_id": "NCT00343668_exc_T4",
"arg2_id": "NCT00343668_exc_T5",
"normalized": []
},
{
"id": "NCT00343668_exc_R3",
"type": "AND",
"arg1_id": "NCT00343668_exc_T9",
"arg2_id": "NCT00343668_exc_T8",
"normalized": []
},
{
... |
NCT00343668_inc | NCT00343668 | [
{
"id": "NCT00343668_inc_text",
"type": "inclusion",
"text": [
"Pathologically proven unresectable adenocarcinoma of stomach \nWith uni-dimensionally measurable disease (at least longest diameter 2 cm on conventional CT scan, x-ray or physical examination, or 1cm on spiral CT scan) \nAge 18 to 70 ... | [
{
"id": "NCT00343668_inc_T1",
"type": "Condition",
"text": [
"adenocarcinoma of stomach"
],
"offsets": [
[
35,
60
]
],
"normalized": []
},
{
"id": "NCT00343668_inc_T2",
"type": "Qualifier",
"text": [
"unresectable"
],
"offse... | [] | [] | [
{
"id": "NCT00343668_inc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00343668_inc_T1",
"arg2_id": "NCT00343668_inc_T2",
"normalized": []
},
{
"id": "NCT00343668_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00343668_inc_T3",
"arg2_id": "NCT00343668_inc_T4",
"normalized": ... |
NCT00344318_exc | NCT00344318 | [
{
"id": "NCT00344318_exc_text",
"type": "exclusion",
"text": [
"Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period \nChronic administration (defined ... | [
{
"id": "NCT00344318_exc_T1",
"type": "Drug",
"text": [
"product",
"any investigational",
"other than the study vaccine(s)"
],
"offsets": [
[
45,
52
],
[
7,
26
],
[
71,
102
]
],
"normali... | [] | [] | [
{
"id": "NCT00344318_exc_R1",
"type": "Subsumes",
"arg1_id": "NCT00344318_exc_T6",
"arg2_id": "NCT00344318_exc_T5",
"normalized": []
},
{
"id": "NCT00344318_exc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00344318_exc_T8",
"arg2_id": "NCT00344318_exc_T9",
"normalized": []... |
NCT00344318_inc | NCT00344318 | [
{
"id": "NCT00344318_inc_text",
"type": "inclusion",
"text": [
"Male or female between, and including, 6-12 weeks (42 to 90 days) of age at the time of the first vaccination. \nSubjects for whom the investigator believes that their parents/guardians can and will comply with the requirements of the... | [
{
"id": "NCT00344318_inc_T1",
"type": "Value",
"text": [
"between",
"6-12 weeks"
],
"offsets": [
[
15,
22
],
[
39,
49
]
],
"normalized": []
},
{
"id": "NCT00344318_inc_T2",
"type": "Value",
"text": [
... | [] | [] | [
{
"id": "NCT00344318_inc_R1",
"type": "Subsumes",
"arg1_id": "NCT00344318_inc_T1",
"arg2_id": "NCT00344318_inc_T2",
"normalized": []
},
{
"id": "NCT00344318_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00344318_inc_T3",
"arg2_id": "NCT00344318_inc_T1",
"normalized": []
... |
NCT00351611_exc | NCT00351611 | [
{
"id": "NCT00351611_exc_text",
"type": "exclusion",
"text": [
"Pre-existing eye diseases (glaucoma).\nInsufficient response to pregabalin in the treatment of partial seizure, or patients currently receiving pregabalin treatment.\n"
],
"offsets": [
[
0,
165
]
... | [
{
"id": "NCT00351611_exc_T1",
"type": "Condition",
"text": [
"eye diseases"
],
"offsets": [
[
13,
25
]
],
"normalized": []
},
{
"id": "NCT00351611_exc_T2",
"type": "Qualifier",
"text": [
"Pre-existing"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00351611_exc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00351611_exc_T1",
"arg2_id": "NCT00351611_exc_T2",
"normalized": []
},
{
"id": "NCT00351611_exc_R2",
"type": "Subsumes",
"arg1_id": "NCT00351611_exc_T1",
"arg2_id": "NCT00351611_exc_T3",
"normalized": [... |
NCT00351611_inc | NCT00351611 | [
{
"id": "NCT00351611_inc_text",
"type": "inclusion",
"text": [
"Epilepsy partial seizure subjects.\nCurrently taking 1 to 3 antiepileptic drugs.\n"
],
"offsets": [
[
0,
80
]
]
}
] | [
{
"id": "NCT00351611_inc_T1",
"type": "Condition",
"text": [
"Epilepsy"
],
"offsets": [
[
0,
8
]
],
"normalized": []
},
{
"id": "NCT00351611_inc_T2",
"type": "Condition",
"text": [
"partial seizure"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00351611_inc_R1",
"type": "AND",
"arg1_id": "NCT00351611_inc_T1",
"arg2_id": "NCT00351611_inc_T2",
"normalized": []
},
{
"id": "NCT00351611_inc_R2",
"type": "Has_multiplier",
"arg1_id": "NCT00351611_inc_T3",
"arg2_id": "NCT00351611_inc_T4",
"normalized": []
... |
NCT00356148_exc | NCT00356148 | [
{
"id": "NCT00356148_exc_text",
"type": "exclusion",
"text": [
"Ductal carcinoma in situ (DCIS; stage 0 cancer), \nAdvanced or distant metastatic stage, \nReceiving any neoadjuvant therapy, \nHistory of receiving any antibiotics within prior 3 months, \nHistory of immunodeficiency, \nHaving a remo... | [
{
"id": "NCT00356148_exc_T1",
"type": "Condition",
"text": [
"Ductal carcinoma in situ"
],
"offsets": [
[
0,
24
]
],
"normalized": []
},
{
"id": "NCT00356148_exc_T2",
"type": "Condition",
"text": [
"DCIS"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00356148_exc_R1",
"type": "AND",
"arg1_id": "NCT00356148_exc_T4",
"arg2_id": "NCT00356148_exc_T3",
"normalized": []
},
{
"id": "NCT00356148_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00356148_exc_T3",
"arg2_id": "NCT00356148_exc_T5",
"normalized": []
},
... |
NCT00356148_inc | NCT00356148 | [
{
"id": "NCT00356148_inc_text",
"type": "inclusion",
"text": [
"Women at any age with early stage breast cancer (stage I-II) and American Society of Anesthesiologists (ASA) score of I-II. \n"
],
"offsets": [
[
0,
125
]
]
}
] | [
{
"id": "NCT00356148_inc_T1",
"type": "Person",
"text": [
"Women"
],
"offsets": [
[
0,
5
]
],
"normalized": []
},
{
"id": "NCT00356148_inc_T2",
"type": "Person",
"text": [
"any age"
],
"offsets": [
[
9,
... | [] | [] | [
{
"id": "NCT00356148_inc_R3",
"type": "Has_value",
"arg1_id": "NCT00356148_inc_T4",
"arg2_id": "NCT00356148_inc_T3",
"normalized": []
},
{
"id": "NCT00356148_inc_R4",
"type": "Has_value",
"arg1_id": "NCT00356148_inc_T6",
"arg2_id": "NCT00356148_inc_T7",
"normalized": []
... |
NCT00379366_exc | NCT00379366 | [
{
"id": "NCT00379366_exc_text",
"type": "exclusion",
"text": [
"contra-indications of radiotherapy \nangioplasty with stenting \n \n"
],
"offsets": [
[
0,
74
]
]
}
] | [
{
"id": "NCT00379366_exc_T1",
"type": "Procedure",
"text": [
"radiotherapy"
],
"offsets": [
[
22,
34
]
],
"normalized": []
},
{
"id": "NCT00379366_exc_T2",
"type": "Condition",
"text": [
"contra-indications"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00379366_exc_R1",
"type": "AND",
"arg1_id": "NCT00379366_exc_T2",
"arg2_id": "NCT00379366_exc_T1",
"normalized": []
}
] |
NCT00379366_inc | NCT00379366 | [
{
"id": "NCT00379366_inc_text",
"type": "inclusion",
"text": [
"over 18 years \nsuccessful angioplasty (residual stenosis < 30%) on a significant stenosis (maximal systolic speed 3 times > from basal maximal systolic speed, stenosis > 70% on angiography) on the venous-prosthesis anastomosis or on ... | [
{
"id": "NCT00379366_inc_T1",
"type": "Value",
"text": [
"over 18 years"
],
"offsets": [
[
0,
13
]
],
"normalized": []
},
{
"id": "NCT00379366_inc_T2",
"type": "Person",
"text": [
"over 18 years"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00379366_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00379366_inc_T2",
"arg2_id": "NCT00379366_inc_T1",
"normalized": []
},
{
"id": "NCT00379366_inc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00379366_inc_T3",
"arg2_id": "NCT00379366_inc_T4",
"normalized": ... |
NCT00391690_exc | NCT00391690 | [
{
"id": "NCT00391690_exc_text",
"type": "exclusion",
"text": [
"Prior treatment with a bisphosphonate \nAbnormal renal function as evidenced by a calculated creatinine clearance < 30 ml/minute. \nCorrected (adjusted for serum albumin) serum calcium concentration < 8.0 mg/dl (2.00 mmol/L) or ≥ 12.0... | [
{
"id": "NCT00391690_exc_T1",
"type": "Drug",
"text": [
"bisphosphonate"
],
"offsets": [
[
23,
37
]
],
"normalized": []
},
{
"id": "NCT00391690_exc_T2",
"type": "Temporal",
"text": [
"Prior"
],
"offsets": [
[
0... | [] | [] | [
{
"id": "NCT00391690_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00391690_exc_T1",
"arg2_id": "NCT00391690_exc_T2",
"normalized": []
},
{
"id": "NCT00391690_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00391690_exc_T3",
"arg2_id": "NCT00391690_exc_T4",
"normalized": [... |
NCT00391690_inc | NCT00391690 | [
{
"id": "NCT00391690_inc_text",
"type": "inclusion",
"text": [
"Patients with histologically confirmed diagnosis of prostate cancer who have not yet developed bone metastases \nProstate cancer patients with a rise in PSA under hormone therapy. \nPSA criteria: \nPatients who have undergone prostate... | [
{
"id": "NCT00391690_inc_T1",
"type": "Measurement",
"text": [
"histologically"
],
"offsets": [
[
14,
28
]
],
"normalized": []
},
{
"id": "NCT00391690_inc_T2",
"type": "Value",
"text": [
"confirmed"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00391690_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00391690_inc_T1",
"arg2_id": "NCT00391690_inc_T2",
"normalized": []
},
{
"id": "NCT00391690_inc_R2",
"type": "AND",
"arg1_id": "NCT00391690_inc_T3",
"arg2_id": "NCT00391690_inc_T1",
"normalized": []
},
... |
NCT00396734_exc | NCT00396734 | [
{
"id": "NCT00396734_exc_text",
"type": "exclusion",
"text": [
"use more than 2g a day; 5 times a week to everyday \nSubjects who are diagnosed as suffering from psychotic illness according to DSM-IV (Axis 1)22, or with a history of CNS disease, a history of infection that might affect CNS (HIV, s... | [
{
"id": "NCT00396734_exc_T1",
"type": "Multiplier",
"text": [
"more than 2g a day"
],
"offsets": [
[
4,
22
]
],
"normalized": []
},
{
"id": "NCT00396734_exc_T2",
"type": "Multiplier",
"text": [
"5 times a week to everyday"
],
... | [] | [] | [
{
"id": "NCT00396734_exc_R1",
"type": "Has_multiplier",
"arg1_id": "NCT00396734_exc_T1",
"arg2_id": "NCT00396734_exc_T2",
"normalized": []
},
{
"id": "NCT00396734_exc_R3",
"type": "Subsumes",
"arg1_id": "NCT00396734_exc_T3",
"arg2_id": "NCT00396734_exc_T4",
"normalized": ... |
NCT00396734_inc | NCT00396734 | [
{
"id": "NCT00396734_inc_text",
"type": "inclusion",
"text": [
"Methadone-maintained cocaine-dependent patients use between 1g to 2g a day; 1 to 3 times a week \n"
],
"offsets": [
[
0,
97
]
]
}
] | [
{
"id": "NCT00396734_inc_T1",
"type": "Drug",
"text": [
"Methadone"
],
"offsets": [
[
0,
9
]
],
"normalized": []
},
{
"id": "NCT00396734_inc_T2",
"type": "Condition",
"text": [
"cocaine-dependent"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00396734_inc_R4",
"type": "Has_qualifier",
"arg1_id": "NCT00396734_inc_T2",
"arg2_id": "NCT00396734_inc_T5",
"normalized": []
},
{
"id": "NCT00396734_inc_R1",
"type": "Has_scope",
"arg1_id": "NCT00396734_inc_T1",
"arg2_id": "NCT00396734_inc_T6",
"normalized": ... |
NCT00397215_exc | NCT00397215 | [
{
"id": "NCT00397215_exc_text",
"type": "exclusion",
"text": [
"Administration of the licensed MF59-containing vaccines, e.g. Fluad™ or Addigrip™ or virosome-based influenza vaccines such as Inflexal V™, InfectoVac Flu™ or Invivac™ during the 2006-2007 influenza season. \nAdministration of license... | [
{
"id": "NCT00397215_exc_T1",
"type": "Drug",
"text": [
"MF59-containing vaccines"
],
"offsets": [
[
31,
55
]
],
"normalized": []
},
{
"id": "NCT00397215_exc_T2",
"type": "Drug",
"text": [
"Fluad"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00397215_exc_R1",
"type": "Subsumes",
"arg1_id": "NCT00397215_exc_T4",
"arg2_id": "NCT00397215_exc_T9",
"normalized": []
},
{
"id": "NCT00397215_exc_R2",
"type": "Subsumes",
"arg1_id": "NCT00397215_exc_T1",
"arg2_id": "NCT00397215_exc_T10",
"normalized": []
... |
NCT00397215_inc | NCT00397215 | [
{
"id": "NCT00397215_inc_text",
"type": "inclusion",
"text": [
"Subjects who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study. \nA male or female aged 61 years or above at the time of the first vaccination. \nWritten info... | [
{
"id": "NCT00397215_inc_T1",
"type": "Person",
"text": [
"aged"
],
"offsets": [
[
158,
162
]
],
"normalized": []
},
{
"id": "NCT00397215_inc_T2",
"type": "Value",
"text": [
"61 years or above"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00397215_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00397215_inc_T1",
"arg2_id": "NCT00397215_inc_T2",
"normalized": []
},
{
"id": "NCT00397215_inc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00397215_inc_T4",
"arg2_id": "NCT00397215_inc_T5",
"normalized": ... |
NCT00401245_exc | NCT00401245 | [
{
"id": "NCT00401245_exc_text",
"type": "exclusion",
"text": [
"History of a seizure disorder other than a single childhood febrile seizure. \nHistory or presence of clinically important hepatic or renal disease or other medical disease. \nPresence or recent history of major depressive disorder, b... | [
{
"id": "NCT00401245_exc_T1",
"type": "Condition",
"text": [
"seizure disorder"
],
"offsets": [
[
13,
29
]
],
"normalized": []
},
{
"id": "NCT00401245_exc_T2",
"type": "Condition",
"text": [
"childhood febrile seizure"
],
"o... | [] | [] | [
{
"id": "NCT00401245_exc_R1",
"type": "Has_multiplier",
"arg1_id": "NCT00401245_exc_T2",
"arg2_id": "NCT00401245_exc_T3",
"normalized": []
},
{
"id": "NCT00401245_exc_R3",
"type": "Has_temporal",
"arg1_id": "NCT00401245_exc_T1",
"arg2_id": "NCT00401245_exc_T4",
"normalize... |
NCT00401245_inc | NCT00401245 | [
{
"id": "NCT00401245_inc_text",
"type": "inclusion",
"text": [
"Generally healthy, postmenopausal woman who seeks treatment for hot flushes. \nMeets 1 of the following: At least 12 months of spontaneous amenorrhea; At least 6 months of spontaneous amenorrhea with serum follicle-stimulating hormone... | [
{
"id": "NCT00401245_inc_T1",
"type": "Condition",
"text": [
"healthy"
],
"offsets": [
[
10,
17
]
],
"normalized": []
},
{
"id": "NCT00401245_inc_T2",
"type": "Condition",
"text": [
"postmenopausal"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00401245_inc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00401245_inc_T6",
"arg2_id": "NCT00401245_inc_T5",
"normalized": []
},
{
"id": "NCT00401245_inc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00401245_inc_T8",
"arg2_id": "NCT00401245_inc_T7",
"normalized"... |
NCT00404495_exc | NCT00404495 | [
{
"id": "NCT00404495_exc_text",
"type": "exclusion",
"text": [
"Diagnosis of brainstem glioma \nConcurrent administration of any other anti-tumor therapy \nPre-existing uncontrolled diarrhea \n \n"
],
"offsets": [
[
0,
137
]
]
}
] | [
{
"id": "NCT00404495_exc_T1",
"type": "Condition",
"text": [
"brainstem glioma"
],
"offsets": [
[
13,
29
]
],
"normalized": []
},
{
"id": "NCT00404495_exc_T2",
"type": "Procedure",
"text": [
"anti-tumor therapy"
],
"offsets"... | [] | [] | [
{
"id": "NCT00404495_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00404495_exc_T2",
"arg2_id": "NCT00404495_exc_T4",
"normalized": []
},
{
"id": "NCT00404495_exc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00404495_exc_T2",
"arg2_id": "NCT00404495_exc_T5",
"normalized... |
NCT00404495_inc | NCT00404495 | [
{
"id": "NCT00404495_inc_text",
"type": "inclusion",
"text": [
"Cohort 1: Recurrent or refractory medulloblastoma in which current standard treatment approaches have failed; biopsy is not required for recurrent disease. \nCohort 2: Newly-diagnosed high-grade glioma (World Health Organization [WHO]... | [
{
"id": "NCT00404495_inc_T1",
"type": "Condition",
"text": [
"refractory medulloblastoma"
],
"offsets": [
[
23,
49
]
],
"normalized": []
},
{
"id": "NCT00404495_inc_T2",
"type": "Condition",
"text": [
"Recurrent",
"medulloblas... | [] | [] | [
{
"id": "NCT00404495_inc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00404495_inc_T3",
"arg2_id": "NCT00404495_inc_T4",
"normalized": []
},
{
"id": "NCT00404495_inc_R2",
"type": "AND",
"arg1_id": "NCT00404495_inc_T5",
"arg2_id": "NCT00404495_inc_T3",
"normalized": []
}... |
NCT00425789_exc | NCT00425789 | [
{
"id": "NCT00425789_exc_text",
"type": "exclusion",
"text": [
"Patients will be excluded if they have known middle ear disease, chronic lung disease or claustrophobia \n \n"
],
"offsets": [
[
0,
116
]
]
}
] | [
{
"id": "NCT00425789_exc_T1",
"type": "Condition",
"text": [
"middle ear disease"
],
"offsets": [
[
45,
63
]
],
"normalized": []
},
{
"id": "NCT00425789_exc_T2",
"type": "Condition",
"text": [
"chronic lung disease"
],
"offs... | [] | [] | [] |
NCT00425789_inc | NCT00425789 | [
{
"id": "NCT00425789_inc_text",
"type": "inclusion",
"text": [
"The study will include 40 post-deep peel women (exoderm), older than 18 years old, treated by the same dermatologist (dr. Landau). \nThe treatment group will receive 5 consecutive daily hyperbaric treatments, 1 hours long each, at 2 A... | [
{
"id": "NCT00425789_inc_T1",
"type": "Condition",
"text": [
"deep peel"
],
"offsets": [
[
31,
40
]
],
"normalized": []
},
{
"id": "NCT00425789_inc_T2",
"type": "Person",
"text": [
"women"
],
"offsets": [
[
41,... | [] | [] | [
{
"id": "NCT00425789_inc_R1",
"type": "Subsumes",
"arg1_id": "NCT00425789_inc_T1",
"arg2_id": "NCT00425789_inc_T3",
"normalized": []
},
{
"id": "NCT00425789_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00425789_inc_T5",
"arg2_id": "NCT00425789_inc_T4",
"normalized": []
... |
NCT00426751_exc | NCT00426751 | [
{
"id": "NCT00426751_exc_text",
"type": "exclusion",
"text": [
"Subjects not able to give informed consent \nLeft Bundle Branch Block \nThrombolytic therapy within 24 hours before randomization \nOral anticoagulation with International Normalized Ratio (INR) > 2 \nKnown platelets < 100.000/µl or k... | [
{
"id": "NCT00426751_exc_T1",
"type": "Condition",
"text": [
"Left Bundle Branch Block"
],
"offsets": [
[
44,
68
]
],
"normalized": []
},
{
"id": "NCT00426751_exc_T2",
"type": "Procedure",
"text": [
"Thrombolytic therapy"
],
... | [] | [] | [
{
"id": "NCT00426751_exc_R1",
"type": "Has_value",
"arg1_id": "NCT00426751_exc_T5",
"arg2_id": "NCT00426751_exc_T6",
"normalized": []
},
{
"id": "NCT00426751_exc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00426751_exc_T12",
"arg2_id": "NCT00426751_exc_T13",
"normalized":... |
NCT00426751_inc | NCT00426751 | [
{
"id": "NCT00426751_inc_text",
"type": "inclusion",
"text": [
"Women must be postmenopausal (i.e.12 months without menstrual period), or surgically sterile, i.e. women of child bearing potential are not allowed to be included into the study. In cases of doubt a pregnancy test should be performed.... | [
{
"id": "NCT00426751_inc_T1",
"type": "Condition",
"text": [
"postmenopausal"
],
"offsets": [
[
14,
28
]
],
"normalized": []
},
{
"id": "NCT00426751_inc_T2",
"type": "Person",
"text": [
"Women"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00426751_inc_R1",
"type": "AND",
"arg1_id": "NCT00426751_inc_T2",
"arg2_id": "NCT00426751_inc_T1",
"normalized": []
},
{
"id": "NCT00426751_inc_R2",
"type": "Has_negation",
"arg1_id": "NCT00426751_inc_T4",
"arg2_id": "NCT00426751_inc_T5",
"normalized": []
},... |
NCT00440245_exc | NCT00440245 | [
{
"id": "NCT00440245_exc_text",
"type": "exclusion",
"text": [
"asthma and COPD\n"
],
"offsets": [
[
0,
16
]
]
}
] | [
{
"id": "NCT00440245_exc_T1",
"type": "Condition",
"text": [
"asthma"
],
"offsets": [
[
0,
6
]
],
"normalized": []
},
{
"id": "NCT00440245_exc_T2",
"type": "Condition",
"text": [
"COPD"
],
"offsets": [
[
11,
... | [] | [] | [] |
NCT00440245_inc | NCT00440245 | [
{
"id": "NCT00440245_inc_text",
"type": "inclusion",
"text": [
"asthma or COPD\n"
],
"offsets": [
[
0,
15
]
]
}
] | [
{
"id": "NCT00440245_inc_T1",
"type": "Condition",
"text": [
"asthma"
],
"offsets": [
[
0,
6
]
],
"normalized": []
},
{
"id": "NCT00440245_inc_T2",
"type": "Condition",
"text": [
"COPD"
],
"offsets": [
[
10,
... | [] | [] | [] |
NCT00445029_exc | NCT00445029 | [
{
"id": "NCT00445029_exc_text",
"type": "exclusion",
"text": [
"Pregnant or lactating women. \nEvolutive skin disease on the testing zone (lower back). \nPatients with a clinically significant disease (chronic, recurrent or active). \nSystemic corticotherapy or immunosuppressive treatment during t... | [
{
"id": "NCT00445029_exc_T1",
"type": "Condition",
"text": [
"Pregnant"
],
"offsets": [
[
0,
8
]
],
"normalized": []
},
{
"id": "NCT00445029_exc_T2",
"type": "Condition",
"text": [
"lactating"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00445029_exc_R1",
"type": "Subsumes",
"arg1_id": "NCT00445029_exc_T5",
"arg2_id": "NCT00445029_exc_T6",
"normalized": []
},
{
"id": "NCT00445029_exc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00445029_exc_T4",
"arg2_id": "NCT00445029_exc_T5",
"normalized": [... |
NCT00445029_inc | NCT00445029 | [
{
"id": "NCT00445029_inc_text",
"type": "inclusion",
"text": [
"For both groups: \nPatients aged from 18 to 65 years old. \nBoth genders eligible for study. \nFemale participants must use a contraceptive method. \nFeasibility of patch testing. \nParticipants must be able to understand and sign the... | [
{
"id": "NCT00445029_inc_T1",
"type": "Person",
"text": [
"aged"
],
"offsets": [
[
27,
31
]
],
"normalized": []
},
{
"id": "NCT00445029_inc_T2",
"type": "Value",
"text": [
"from 18 to 65 years old"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00445029_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00445029_inc_T1",
"arg2_id": "NCT00445029_inc_T2",
"normalized": []
},
{
"id": "NCT00445029_inc_R2",
"type": "AND",
"arg1_id": "NCT00445029_inc_T3",
"arg2_id": "NCT00445029_inc_T4",
"normalized": []
},
... |
NCT00455663_exc | NCT00455663 | [
{
"id": "NCT00455663_exc_text",
"type": "exclusion",
"text": [
"History of significant head trauma, seizure disorder, or mental retardation \nHistory of alcohol or drug abuse or dependence within 1 month prior to study entry \nHistory of violence within 6 months prior to study entry \n \n... | [
{
"id": "NCT00455663_exc_T1",
"type": "Condition",
"text": [
"head trauma"
],
"offsets": [
[
23,
34
]
],
"normalized": []
},
{
"id": "NCT00455663_exc_T2",
"type": "Condition",
"text": [
"seizure disorder"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00455663_exc_R1",
"type": "Has_scope",
"arg1_id": "NCT00455663_exc_T4",
"arg2_id": "NCT00455663_exc_T5",
"normalized": []
},
{
"id": "NCT00455663_exc_R2",
"type": "Has_scope",
"arg1_id": "NCT00455663_exc_T6",
"arg2_id": "NCT00455663_exc_T12",
"normalized": []
... |
NCT00455663_inc | NCT00455663 | [
{
"id": "NCT00455663_inc_text",
"type": "inclusion",
"text": [
"Diagnosis of schizophrenia or schizoaffective disorder \nIf entering the study as an inpatient, hospitalization was recent \nCurrently receiving treatment with an atypical antipsychotic and continuation on the medication has been reco... | [
{
"id": "NCT00455663_inc_T1",
"type": "Condition",
"text": [
"schizophrenia"
],
"offsets": [
[
13,
26
]
],
"normalized": []
},
{
"id": "NCT00455663_inc_T2",
"type": "Condition",
"text": [
"schizoaffective disorder"
],
"offse... | [] | [] | [
{
"id": "NCT00455663_inc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00455663_inc_T6",
"arg2_id": "NCT00455663_inc_T7",
"normalized": []
},
{
"id": "NCT00455663_inc_R2",
"type": "AND",
"arg1_id": "NCT00455663_inc_T5",
"arg2_id": "NCT00455663_inc_T6",
"normalized": []
},... |
NCT00461136_exc | NCT00461136 | [
{
"id": "NCT00461136_exc_text",
"type": "exclusion",
"text": [
"Severe Hypertension Grade 3 WHO classification (Mean Sitting Diastolic Blood Pressure (MSDBP) 110 mmHg and/or Mean Sitting Systolic Blood Pressure MSSBP 180 mmHg) \nAcetylsalicyclic acid (ASA) treatment >1g/day or regular use of Non s... | [
{
"id": "NCT00461136_exc_T1",
"type": "Condition",
"text": [
"Severe Hypertension"
],
"offsets": [
[
0,
19
]
],
"normalized": []
},
{
"id": "NCT00461136_exc_T2",
"type": "Measurement",
"text": [
"Grade",
"WHO classification"
... | [] | [] | [
{
"id": "NCT00461136_exc_R1",
"type": "Has_value",
"arg1_id": "NCT00461136_exc_T2",
"arg2_id": "NCT00461136_exc_T3",
"normalized": []
},
{
"id": "NCT00461136_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00461136_exc_T4",
"arg2_id": "NCT00461136_exc_T5",
"normalized": []
... |
NCT00461136_inc | NCT00461136 | [
{
"id": "NCT00461136_inc_text",
"type": "inclusion",
"text": [
"Male and/or female patients from 30-80 years of age with a diagnosis of Type 2 diabetes (WHO criteria). \nIncipient and established diabetic nephropathy (urinary albumin excretion ≥ 100 mg/day but ≤ 2000 mg/day). \nGlomerular filtrati... | [
{
"id": "NCT00461136_inc_T1",
"type": "Value",
"text": [
"30-80 years"
],
"offsets": [
[
33,
44
]
],
"normalized": []
},
{
"id": "NCT00461136_inc_T3",
"type": "Condition",
"text": [
"Type 2 diabetes"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00461136_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00461136_inc_T2",
"arg2_id": "NCT00461136_inc_T1",
"normalized": []
},
{
"id": "NCT00461136_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00461136_inc_T6",
"arg2_id": "NCT00461136_inc_T5",
"normalized": []
... |
NCT00480129_exc | NCT00480129 | [
{
"id": "NCT00480129_exc_text",
"type": "exclusion",
"text": [
"Ongoing allergen immunotherapy \nupper respiratory tract infection \nPregnancy \nClinical history of lactose-intolerance or allergies to cow-milk \n \n"
],
"offsets": [
[
0,
155
]
]
}... | [
{
"id": "NCT00480129_exc_T1",
"type": "Procedure",
"text": [
"allergen immunotherapy"
],
"offsets": [
[
8,
30
]
],
"normalized": []
},
{
"id": "NCT00480129_exc_T2",
"type": "Condition",
"text": [
"upper respiratory tract infection"
... | [] | [] | [
{
"id": "NCT00480129_exc_R1",
"type": "OR",
"arg1_id": "NCT00480129_exc_T4",
"arg2_id": "NCT00480129_exc_T5",
"normalized": []
}
] |
NCT00480129_inc | NCT00480129 | [
{
"id": "NCT00480129_inc_text",
"type": "inclusion",
"text": [
"Clinical diagnosis of allergic rhinitis based on sneeze attacks, runny/blocked/itchy nose in the absence of a common cold during the previous 12 months. \nHistory of positive skin prick test or blood radio-allergosorbent test (RAST) t... | [
{
"id": "NCT00480129_inc_T1",
"type": "Condition",
"text": [
"allergic rhinitis"
],
"offsets": [
[
22,
39
]
],
"normalized": []
},
{
"id": "NCT00480129_inc_T2",
"type": "Condition",
"text": [
"sneeze attacks"
],
"offsets": [... | [] | [] | [
{
"id": "NCT00480129_inc_R1",
"type": "Subsumes",
"arg1_id": "NCT00480129_inc_T1",
"arg2_id": "NCT00480129_inc_T2",
"normalized": []
},
{
"id": "NCT00480129_inc_R2",
"type": "Has_negation",
"arg1_id": "NCT00480129_inc_T6",
"arg2_id": "NCT00480129_inc_T7",
"normalized": []... |
NCT00483106_exc | NCT00483106 | [
{
"id": "NCT00483106_exc_text",
"type": "exclusion",
"text": [
"Psychosis\nTourette syndrome\nIntelligence quotient (IQ) < 70\nPervasive developmental disorder (PDD)\n"
],
"offsets": [
[
0,
99
]
]
}
] | [
{
"id": "NCT00483106_exc_T1",
"type": "Condition",
"text": [
"Psychosis"
],
"offsets": [
[
0,
9
]
],
"normalized": []
},
{
"id": "NCT00483106_exc_T2",
"type": "Condition",
"text": [
"Tourette syndrome"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00483106_exc_R1",
"type": "Subsumes",
"arg1_id": "NCT00483106_exc_T3",
"arg2_id": "NCT00483106_exc_T4",
"normalized": []
},
{
"id": "NCT00483106_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00483106_exc_T3",
"arg2_id": "NCT00483106_exc_T5",
"normalized": []
... |
NCT00483106_inc | NCT00483106 | [
{
"id": "NCT00483106_inc_text",
"type": "inclusion",
"text": [
"ADHD\n"
],
"offsets": [
[
0,
5
]
]
}
] | [
{
"id": "NCT00483106_inc_T1",
"type": "Condition",
"text": [
"ADHD"
],
"offsets": [
[
0,
4
]
],
"normalized": []
}
] | [] | [] | [] |
NCT00500500_exc | NCT00500500 | [
{
"id": "NCT00500500_exc_text",
"type": "exclusion",
"text": [
"patient already treated by medicines which could interfere with the study \nlow level of vitamin B12 and folate which are considered as clinically relevant \nclinically relevant pathologies (eg: pulmonary illness, cardiovascular illne... | [
{
"id": "NCT00500500_exc_T2",
"type": "Measurement",
"text": [
"level of vitamin B12"
],
"offsets": [
[
79,
99
]
],
"normalized": []
},
{
"id": "NCT00500500_exc_T3",
"type": "Value",
"text": [
"low"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00500500_exc_R1",
"type": "Has_value",
"arg1_id": "NCT00500500_exc_T2",
"arg2_id": "NCT00500500_exc_T3",
"normalized": []
},
{
"id": "NCT00500500_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00500500_exc_T4",
"arg2_id": "NCT00500500_exc_T3",
"normalized": []
... |
NCT00500500_inc | NCT00500500 | [
{
"id": "NCT00500500_inc_text",
"type": "inclusion",
"text": [
"female or male of 50 to 85 years old with a care giver \nMini Mental Status (MMS) test between 16 to 26 inclusive \nClinical Dementia Rating (CDR) test inferior or equal to 1 \nNational Institute of Neurological and Communicative Diso... | [
{
"id": "NCT00500500_inc_T1",
"type": "Value",
"text": [
"50 to 85 years"
],
"offsets": [
[
18,
32
]
],
"normalized": []
},
{
"id": "NCT00500500_inc_T2",
"type": "Person",
"text": [
"old"
],
"offsets": [
[
33,
... | [] | [] | [
{
"id": "NCT00500500_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00500500_inc_T2",
"arg2_id": "NCT00500500_inc_T1",
"normalized": []
},
{
"id": "NCT00500500_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00500500_inc_T3",
"arg2_id": "NCT00500500_inc_T4",
"normalized": []
... |
NCT00502567_exc | NCT00502567 | [
{
"id": "NCT00502567_exc_text",
"type": "exclusion",
"text": [
"Inadequate bone marrow reserve \nhistory of poorly controlled hypertension \n \n"
],
"offsets": [
[
0,
86
]
]
}
] | [
{
"id": "NCT00502567_exc_T1",
"type": "Condition",
"text": [
"Inadequate bone marrow reserve"
],
"offsets": [
[
0,
30
]
],
"normalized": []
},
{
"id": "NCT00502567_exc_T2",
"type": "Condition",
"text": [
"poorly controlled hypertens... | [] | [] | [
{
"id": "NCT00502567_exc_R1",
"type": "AND",
"arg1_id": "NCT00502567_exc_T3",
"arg2_id": "NCT00502567_exc_T2",
"normalized": []
}
] |
NCT00502567_inc | NCT00502567 | [
{
"id": "NCT00502567_inc_text",
"type": "inclusion",
"text": [
"histologically confirmed metastatic cancer that is not amenable to surgery or radiation therapy with curative intent \nmeasurable lesion by CT or other techniques according to RECIST \n"
],
"offsets": [
[
0,
... | [
{
"id": "NCT00502567_inc_T1",
"type": "Condition",
"text": [
"metastatic cancer"
],
"offsets": [
[
25,
42
]
],
"normalized": []
},
{
"id": "NCT00502567_inc_T2",
"type": "Measurement",
"text": [
"histologically"
],
"offsets":... | [] | [] | [
{
"id": "NCT00502567_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00502567_inc_T2",
"arg2_id": "NCT00502567_inc_T3",
"normalized": []
},
{
"id": "NCT00502567_inc_R2",
"type": "AND",
"arg1_id": "NCT00502567_inc_T1",
"arg2_id": "NCT00502567_inc_T2",
"normalized": []
},
... |
NCT00527826_exc | NCT00527826 | [
{
"id": "NCT00527826_exc_text",
"type": "exclusion",
"text": [
"Known other respiratory disorders or signs for other respiratory disorders (e.g. asthma, lung cancer, sarcoidosis, tuberculosis, lung fibrosis, cystic fibrosis, bronchoectasis). \nKnown history of significant inflammatory disease, oth... | [
{
"id": "NCT00527826_exc_T1",
"type": "Condition",
"text": [
"respiratory disorders"
],
"offsets": [
[
12,
33
]
],
"normalized": []
},
{
"id": "NCT00527826_exc_T2",
"type": "Condition",
"text": [
"signs for",
"respiratory diso... | [] | [] | [
{
"id": "NCT00527826_exc_R1",
"type": "Subsumes",
"arg1_id": "NCT00527826_exc_T11",
"arg2_id": "NCT00527826_exc_T10",
"normalized": []
},
{
"id": "NCT00527826_exc_R2",
"type": "Has_negation",
"arg1_id": "NCT00527826_exc_T13",
"arg2_id": "NCT00527826_exc_T16",
"normalized"... |
NCT00527826_inc | NCT00527826 | [
{
"id": "NCT00527826_inc_text",
"type": "inclusion",
"text": [
"Subject must have a diagnosis of COPD based on the American Thoracic Society (ATS)/ European Respiratory Society (ERS) criteria. \nMale or female subjects, aged >=40 years. Females must be of Non Child Bearing Potential. The definitio... | [
{
"id": "NCT00527826_inc_T1",
"type": "Condition",
"text": [
"COPD"
],
"offsets": [
[
33,
37
]
],
"normalized": []
},
{
"id": "NCT00527826_inc_T2",
"type": "Measurement",
"text": [
"American Thoracic Society (ATS)/ European Respirat... | [] | [] | [
{
"id": "NCT00527826_inc_R1",
"type": "AND",
"arg1_id": "NCT00527826_inc_T1",
"arg2_id": "NCT00527826_inc_T2",
"normalized": []
},
{
"id": "NCT00527826_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00527826_inc_T4",
"arg2_id": "NCT00527826_inc_T3",
"normalized": []
},
... |
NCT00543712_exc | NCT00543712 | [
{
"id": "NCT00543712_exc_text",
"type": "exclusion",
"text": [
"Systemic therapy or radiotherapy within 4 weeks prior to Day 1 \nPrior therapy with agents targeting the DR5 apoptosis pathway \nMajor surgical procedure, open biopsy, or significant traumatic injury within 4 weeks prior to Day 1, or ... | [
{
"id": "NCT00543712_exc_T1",
"type": "Procedure",
"text": [
"Systemic therapy"
],
"offsets": [
[
0,
16
]
],
"normalized": []
},
{
"id": "NCT00543712_exc_T2",
"type": "Procedure",
"text": [
"radiotherapy"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00543712_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00543712_exc_T5",
"arg2_id": "NCT00543712_exc_T3",
"normalized": []
},
{
"id": "NCT00543712_exc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00543712_exc_T13",
"arg2_id": "NCT00543712_exc_T12",
"normaliz... |
NCT00543712_inc | NCT00543712 | [
{
"id": "NCT00543712_inc_text",
"type": "inclusion",
"text": [
"Ability to understand and willingness to sign a written informed consent document \nAge ≥ 18 years \nHistologic diagnosis of chondrosarcoma, verifiable after enrollment \nMeasurable disease \nPreviously treated or incurable disease wi... | [
{
"id": "NCT00543712_inc_T1",
"type": "Person",
"text": [
"Age"
],
"offsets": [
[
83,
86
]
],
"normalized": []
},
{
"id": "NCT00543712_inc_T2",
"type": "Value",
"text": [
"≥ 18 years"
],
"offsets": [
[
87,
... | [] | [] | [
{
"id": "NCT00543712_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00543712_inc_T1",
"arg2_id": "NCT00543712_inc_T2",
"normalized": []
},
{
"id": "NCT00543712_inc_R2",
"type": "AND",
"arg1_id": "NCT00543712_inc_T3",
"arg2_id": "NCT00543712_inc_T4",
"normalized": []
},
... |
NCT00576173_exc | NCT00576173 | [
{
"id": "NCT00576173_exc_text",
"type": "exclusion",
"text": [
"Patients who have taken either morphine with daily dose more than 120mg or Fentanyl with daily dose more than 50ug/hr \nPatients with significant abnormalities in hepatic or renal function which would, in the opinion of the investigat... | [
{
"id": "NCT00576173_exc_T1",
"type": "Drug",
"text": [
"morphine"
],
"offsets": [
[
31,
39
]
],
"normalized": []
},
{
"id": "NCT00576173_exc_T2",
"type": "Multiplier",
"text": [
"daily dose more than 120mg"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00576173_exc_R1",
"type": "Has_multiplier",
"arg1_id": "NCT00576173_exc_T1",
"arg2_id": "NCT00576173_exc_T2",
"normalized": []
},
{
"id": "NCT00576173_exc_R2",
"type": "Has_multiplier",
"arg1_id": "NCT00576173_exc_T3",
"arg2_id": "NCT00576173_exc_T4",
"normali... |
NCT00576173_inc | NCT00576173 | [
{
"id": "NCT00576173_inc_text",
"type": "inclusion",
"text": [
"Patients with a histologically, radiologically or haematologically confirmed malignancy whose pain is judged by the investigator to be caused by the malignancy \nPatients must have been on a stable daily dose of weak opioids or strong... | [
{
"id": "NCT00576173_inc_T1",
"type": "Procedure",
"text": [
"histologically"
],
"offsets": [
[
16,
30
]
],
"normalized": []
},
{
"id": "NCT00576173_inc_T2",
"type": "Procedure",
"text": [
"radiologically"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00576173_inc_R1",
"type": "AND",
"arg1_id": "NCT00576173_inc_T5",
"arg2_id": "NCT00576173_inc_T6",
"normalized": []
},
{
"id": "NCT00576173_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00576173_inc_T7",
"arg2_id": "NCT00576173_inc_T4",
"normalized": []
},
... |
NCT00586898_exc | NCT00586898 | [
{
"id": "NCT00586898_exc_text",
"type": "exclusion",
"text": [
"Clinically significant cardiac disease (New York Heart Association Class III/IV),or severe debilitating puhnonary disease. \nUncontrolled serious active infection. \nAnticipated survival of less than 3 months. \nActive CNS or epidural... | [
{
"id": "NCT00586898_exc_T1",
"type": "Condition",
"text": [
"cardiac disease"
],
"offsets": [
[
23,
38
]
],
"normalized": []
},
{
"id": "NCT00586898_exc_T2",
"type": "Measurement",
"text": [
"New York Heart Association"
],
... | [] | [] | [
{
"id": "NCT00586898_exc_R1",
"type": "Has_value",
"arg1_id": "NCT00586898_exc_T2",
"arg2_id": "NCT00586898_exc_T3",
"normalized": []
},
{
"id": "NCT00586898_exc_R2",
"type": "Subsumes",
"arg1_id": "NCT00586898_exc_T4",
"arg2_id": "NCT00586898_exc_T2",
"normalized": []
... |
NCT00586898_inc | NCT00586898 | [
{
"id": "NCT00586898_inc_text",
"type": "inclusion",
"text": [
"-Patients residing in the following clinical states wit! be considered: A. Rising PSA: Patients with a history of localized disease who have undergone definitive radiation or surgery. These patients must demonstrate progression of dis... | [
{
"id": "NCT00586898_inc_T3",
"type": "Measurement",
"text": [
"PSA"
],
"offsets": [
[
82,
85
]
],
"normalized": []
},
{
"id": "NCT00586898_inc_T4",
"type": "Value",
"text": [
"Rising"
],
"offsets": [
[
75,
... | [] | [] | [
{
"id": "NCT00586898_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00586898_inc_T3",
"arg2_id": "NCT00586898_inc_T4",
"normalized": []
},
{
"id": "NCT00586898_inc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00586898_inc_T10",
"arg2_id": "NCT00586898_inc_T9",
"normalized":... |
NCT00599924_exc | NCT00599924 | [
{
"id": "NCT00599924_exc_text",
"type": "exclusion",
"text": [
"Prior treatment with more than 6 cycles of traditional alkylating agent-based chemotherapy regimens \nPrior treatment with more than 2 cycles of carboplating-based chemotherapy regimens \nFor colorectal cancer patients in the expanded... | [
{
"id": "NCT00599924_exc_T1",
"type": "Procedure",
"text": [
"treatment"
],
"offsets": [
[
6,
15
]
],
"normalized": []
},
{
"id": "NCT00599924_exc_T2",
"type": "Temporal",
"text": [
"Prior"
],
"offsets": [
[
0,... | [] | [] | [
{
"id": "NCT00599924_exc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00599924_exc_T3",
"arg2_id": "NCT00599924_exc_T4",
"normalized": []
},
{
"id": "NCT00599924_exc_R4",
"type": "Has_qualifier",
"arg1_id": "NCT00599924_exc_T10",
"arg2_id": "NCT00599924_exc_T6",
"normaliz... |
NCT00599924_inc | NCT00599924 | [
{
"id": "NCT00599924_inc_text",
"type": "inclusion",
"text": [
"Advanced solid tumor malignancy (during expansion at the maximum tolerated dose, entry will be limited to patients wtih adenocarcinoma of the colon or rectum) \nEastern Cooperative Oncology Group (ECOG) 0 or 1 \n"
],
"offsets"... | [
{
"id": "NCT00599924_inc_T1",
"type": "Condition",
"text": [
"Advanced solid tumor malignancy"
],
"offsets": [
[
0,
31
]
],
"normalized": []
},
{
"id": "NCT00599924_inc_T3",
"type": "Measurement",
"text": [
"Eastern Cooperative Onco... | [] | [] | [
{
"id": "NCT00599924_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00599924_inc_T3",
"arg2_id": "NCT00599924_inc_T4",
"normalized": []
}
] |
NCT00609531_exc | NCT00609531 | [
{
"id": "NCT00609531_exc_text",
"type": "exclusion",
"text": [
"Age less than 10 years or greater than 55 years, at time of consent \nEstimated IQ < 70 \nUncontrolled epilepsy (seizure within 6 months prior to consent) \n4. Presence of medical conditions that might interfere with participation, or... | [
{
"id": "NCT00609531_exc_T1",
"type": "Person",
"text": [
"Age"
],
"offsets": [
[
0,
3
]
],
"normalized": []
},
{
"id": "NCT00609531_exc_T2",
"type": "Value",
"text": [
"less than 10 years"
],
"offsets": [
[
4,... | [] | [] | [
{
"id": "NCT00609531_exc_R1",
"type": "Has_scope",
"arg1_id": "NCT00609531_exc_T1",
"arg2_id": "NCT00609531_exc_T4",
"normalized": []
},
{
"id": "NCT00609531_exc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00609531_exc_T1",
"arg2_id": "NCT00609531_exc_T5",
"normalized": [... |
NCT00609531_inc | NCT00609531 | [
{
"id": "NCT00609531_inc_text",
"type": "inclusion",
"text": [
"Ambulatory status (outpatient) at time of consent \nAge 10-55 years \nClinical diagnosis of Autism Spectrum Disorder \nIQ greater than or equal to 70 \nScore greater than 8 on Children's Yale-Brown Obsessive Compulsive Scale \nFree of... | [
{
"id": "NCT00609531_inc_T1",
"type": "Visit",
"text": [
"Ambulatory status"
],
"offsets": [
[
0,
17
]
],
"normalized": []
},
{
"id": "NCT00609531_inc_T2",
"type": "Visit",
"text": [
"outpatient"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00609531_inc_R1",
"type": "Subsumes",
"arg1_id": "NCT00609531_inc_T1",
"arg2_id": "NCT00609531_inc_T2",
"normalized": []
},
{
"id": "NCT00609531_inc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00609531_inc_T1",
"arg2_id": "NCT00609531_inc_T3",
"normalized": []... |
NCT00625742_exc | NCT00625742 | [
{
"id": "NCT00625742_exc_text",
"type": "exclusion",
"text": [
"1. Have dementia or delirium (as determined by the palliative care specialist) at study entry. \n2. Are pregnant \n3. Have been taking corticosteroids for longer than 48 hours. \n4. Have pulmonary edema, ascites or pitting edema on cl... | [
{
"id": "NCT00625742_exc_T1",
"type": "Condition",
"text": [
"dementia"
],
"offsets": [
[
8,
16
]
],
"normalized": []
},
{
"id": "NCT00625742_exc_T2",
"type": "Condition",
"text": [
"delirium"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00625742_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00625742_exc_T4",
"arg2_id": "NCT00625742_exc_T3",
"normalized": []
},
{
"id": "NCT00625742_exc_R3",
"type": "Has_qualifier",
"arg1_id": "NCT00625742_exc_T13",
"arg2_id": "NCT00625742_exc_T14",
"normaliz... |
NCT00625742_inc | NCT00625742 | [
{
"id": "NCT00625742_inc_text",
"type": "inclusion",
"text": [
"1. Are referred to the Cachexia Clinic with involuntary weight loss of >5% of their premorbid weight within the previous 6 months. \n2. Are 18 years of age or older \n3. Have a Karnofsky performance score of 60 or higher. \n4. Can mai... | [
{
"id": "NCT00625742_inc_T1",
"type": "Visit",
"text": [
"Cachexia Clinic"
],
"offsets": [
[
23,
38
]
],
"normalized": []
},
{
"id": "NCT00625742_inc_T2",
"type": "Condition",
"text": [
"involuntary weight loss"
],
"offsets"... | [] | [] | [
{
"id": "NCT00625742_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00625742_inc_T2",
"arg2_id": "NCT00625742_inc_T3",
"normalized": []
},
{
"id": "NCT00625742_inc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00625742_inc_T2",
"arg2_id": "NCT00625742_inc_T4",
"normalized": [... |
NCT00639795_exc | NCT00639795 | [
{
"id": "NCT00639795_exc_text",
"type": "exclusion",
"text": [
"Age less than 18 \nClinical or laboratory evidence of systemic infection \nCurrent pregnancy as assessed by preoperative urine HCG test \nSerious, uncontrolled, non-malignant illness \nMalignant illness requiring systemic chemotherapy... | [
{
"id": "NCT00639795_exc_T1",
"type": "Person",
"text": [
"Age"
],
"offsets": [
[
0,
3
]
],
"normalized": []
},
{
"id": "NCT00639795_exc_T2",
"type": "Value",
"text": [
"less than 18"
],
"offsets": [
[
4,
... | [] | [] | [
{
"id": "NCT00639795_exc_R1",
"type": "Has_value",
"arg1_id": "NCT00639795_exc_T1",
"arg2_id": "NCT00639795_exc_T2",
"normalized": []
},
{
"id": "NCT00639795_exc_R2",
"type": "Has_value",
"arg1_id": "NCT00639795_exc_T5",
"arg2_id": "NCT00639795_exc_T6",
"normalized": []
... |
NCT00639795_inc | NCT00639795 | [
{
"id": "NCT00639795_inc_text",
"type": "inclusion",
"text": [
"Age greater than 18 \nPlanned thoracoscopy with low probability(by surgeon estimate) of conversion to open procedure \n"
],
"offsets": [
[
0,
117
]
]
}
] | [
{
"id": "NCT00639795_inc_T1",
"type": "Person",
"text": [
"Age"
],
"offsets": [
[
0,
3
]
],
"normalized": []
},
{
"id": "NCT00639795_inc_T2",
"type": "Value",
"text": [
"greater than 18"
],
"offsets": [
[
4,
... | [] | [] | [
{
"id": "NCT00639795_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00639795_inc_T1",
"arg2_id": "NCT00639795_inc_T2",
"normalized": []
},
{
"id": "NCT00639795_inc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00639795_inc_T3",
"arg2_id": "NCT00639795_inc_T4",
"normalized": ... |
NCT00650312_exc | NCT00650312 | [
{
"id": "NCT00650312_exc_text",
"type": "exclusion",
"text": [
"1. Institutionalized subjects will not be used. 2 Social Habits: \n1. Use of any tobacco products. \n2. Ingestion of any alcoholic, caffeine- or xanthine-containing food or beverage within the 48 hours prior to the initial dose of stu... | [
{
"id": "NCT00650312_exc_T5",
"type": "Drug",
"text": [
"tobacco products"
],
"offsets": [
[
80,
96
]
],
"normalized": []
},
{
"id": "NCT00650312_exc_T17",
"type": "Drug",
"text": [
"medication"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00650312_exc_R1",
"type": "Has_index",
"arg1_id": "NCT00650312_exc_T18",
"arg2_id": "NCT00650312_exc_T19",
"normalized": []
},
{
"id": "NCT00650312_exc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00650312_exc_T17",
"arg2_id": "NCT00650312_exc_T18",
"normalized... |
NCT00650312_inc | NCT00650312 | [
{
"id": "NCT00650312_inc_text",
"type": "inclusion",
"text": [
"1. Age: 18 years and older. \n2. Sex: Male and non-pregnant, non-lactating female \n1. Women of childbearing potential must have negative serum (Beta HCG) pregnancy tests performed within 14 days prior to the start of the study and on... | [
{
"id": "NCT00650312_inc_T1",
"type": "Value",
"text": [
"18 years and older"
],
"offsets": [
[
8,
26
]
],
"normalized": []
},
{
"id": "NCT00650312_inc_T2",
"type": "Person",
"text": [
"Age"
],
"offsets": [
[
3... | [] | [] | [
{
"id": "NCT00650312_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00650312_inc_T2",
"arg2_id": "NCT00650312_inc_T1",
"normalized": []
},
{
"id": "NCT00650312_inc_R2",
"type": "Has_negation",
"arg1_id": "NCT00650312_inc_T7",
"arg2_id": "NCT00650312_inc_T6",
"normalized": [... |
NCT00676273_exc | NCT00676273 | [
{
"id": "NCT00676273_exc_text",
"type": "exclusion",
"text": [
"Patients: \nWho are pregnant or planning to become pregnant during the study or in the future \nWith a elevated post-void residual (defined as PVR > 100cc) \nWith a bleeding condition or on anti-coagulant therapy \nWith immunosuppress... | [
{
"id": "NCT00676273_exc_T3",
"type": "Measurement",
"text": [
"post-void residual"
],
"offsets": [
[
110,
128
]
],
"normalized": []
},
{
"id": "NCT00676273_exc_T4",
"type": "Measurement",
"text": [
"PVR"
],
"offsets": [
... | [] | [] | [
{
"id": "NCT00676273_exc_R1",
"type": "Has_value",
"arg1_id": "NCT00676273_exc_T4",
"arg2_id": "NCT00676273_exc_T5",
"normalized": []
},
{
"id": "NCT00676273_exc_R2",
"type": "Subsumes",
"arg1_id": "NCT00676273_exc_T3",
"arg2_id": "NCT00676273_exc_T4",
"normalized": []
... |
NCT00676273_inc | NCT00676273 | [
{
"id": "NCT00676273_inc_text",
"type": "inclusion",
"text": [
"Are at least 18 years of age \nDemonstrate a positive cough stress test during complex multi-channel urodynamic testing \nDemonstrate impact of stress urinary incontinence on quality of life questionnaire \nAre able to comprehend and ... | [
{
"id": "NCT00676273_inc_T1",
"type": "Value",
"text": [
"at least 18 years"
],
"offsets": [
[
4,
21
]
],
"normalized": []
},
{
"id": "NCT00676273_inc_T2",
"type": "Person",
"text": [
"age"
],
"offsets": [
[
25... | [] | [] | [
{
"id": "NCT00676273_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00676273_inc_T2",
"arg2_id": "NCT00676273_inc_T1",
"normalized": []
},
{
"id": "NCT00676273_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00676273_inc_T3",
"arg2_id": "NCT00676273_inc_T4",
"normalized": []
... |
NCT00679341_exc | NCT00679341 | [
{
"id": "NCT00679341_exc_text",
"type": "exclusion",
"text": [
"History of any chemotherapy for MBC. \nAn interval of < 6 months from the completion of cytotoxic chemotherapy in the neo-adjuvant or adjuvant setting until the time of metastatic diagnosis. \nTrastuzumab ≤ 21 days prior to randomizat... | [
{
"id": "NCT00679341_exc_T1",
"type": "Procedure",
"text": [
"chemotherapy"
],
"offsets": [
[
15,
27
]
],
"normalized": []
},
{
"id": "NCT00679341_exc_T2",
"type": "Condition",
"text": [
"MBC"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00679341_exc_R3",
"type": "Has_temporal",
"arg1_id": "NCT00679341_exc_T9",
"arg2_id": "NCT00679341_exc_T10",
"normalized": []
},
{
"id": "NCT00679341_exc_R4",
"type": "Has_index",
"arg1_id": "NCT00679341_exc_T13",
"arg2_id": "NCT00679341_exc_T14",
"normalized"... |
NCT00679341_inc | NCT00679341 | [
{
"id": "NCT00679341_inc_text",
"type": "inclusion",
"text": [
"Histologically or cytologically confirmed adenocarcinoma of the breast with locally advanced or metastatic disease, and a candidate for chemotherapy. \nHuman epidermal growth factor receptor 2 (HER2)-positive. \nNo prior chemotherapy ... | [
{
"id": "NCT00679341_inc_T1",
"type": "Qualifier",
"text": [
"cytologically confirmed"
],
"offsets": [
[
18,
41
]
],
"normalized": []
},
{
"id": "NCT00679341_inc_T2",
"type": "Qualifier",
"text": [
"Histologically",
"confirmed... | [] | [] | [
{
"id": "NCT00679341_inc_R2",
"type": "AND",
"arg1_id": "NCT00679341_inc_T3",
"arg2_id": "NCT00679341_inc_T5",
"normalized": []
},
{
"id": "NCT00679341_inc_R3",
"type": "AND",
"arg1_id": "NCT00679341_inc_T3",
"arg2_id": "NCT00679341_inc_T4",
"normalized": []
},
{
... |
NCT00718952_exc | NCT00718952 | [
{
"id": "NCT00718952_exc_text",
"type": "exclusion",
"text": [
"The other types of pulmonary hypertension. \nSubjects who refuse to subscribe written informed consents or can't cooperate with the trial well. \nSubjects with serious acute or chronic disease involved liver, kidney, and brain or have... | [
{
"id": "NCT00718952_exc_T1",
"type": "Condition",
"text": [
"pulmonary hypertension"
],
"offsets": [
[
19,
41
]
],
"normalized": []
},
{
"id": "NCT00718952_exc_T3",
"type": "Condition",
"text": [
"chronic disease involved liver"
... | [] | [] | [
{
"id": "NCT00718952_exc_R1",
"type": "Has_temporal",
"arg1_id": "NCT00718952_exc_T8",
"arg2_id": "NCT00718952_exc_T4",
"normalized": []
},
{
"id": "NCT00718952_exc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00718952_exc_T8",
"arg2_id": "NCT00718952_exc_T5",
"normalized... |
NCT00718952_inc | NCT00718952 | [
{
"id": "NCT00718952_inc_text",
"type": "inclusion",
"text": [
"Subjects aged 12-65. \nConfirmed idiopathic pulmonary hypertension, connective tissue disease associated pulmonary hypertension, congenital heart disease(with Eisenmenger syndrome) associated pulmonary hypertension. \nBaseline 6-minut... | [
{
"id": "NCT00718952_inc_T1",
"type": "Person",
"text": [
"aged"
],
"offsets": [
[
9,
13
]
],
"normalized": []
},
{
"id": "NCT00718952_inc_T2",
"type": "Value",
"text": [
"12-65"
],
"offsets": [
[
14,
1... | [] | [] | [
{
"id": "NCT00718952_inc_R1",
"type": "Has_value",
"arg1_id": "NCT00718952_inc_T1",
"arg2_id": "NCT00718952_inc_T2",
"normalized": []
},
{
"id": "NCT00718952_inc_R2",
"type": "AND",
"arg1_id": "NCT00718952_inc_T6",
"arg2_id": "NCT00718952_inc_T7",
"normalized": []
},
... |
NCT00720031_exc | NCT00720031 | [
{
"id": "NCT00720031_exc_text",
"type": "exclusion",
"text": [
"Cardio-vascular pathologies, evoluting and uncontrolled, (severe HTA), cardiac deficiency, severe angor, severe arrhythmia. \nInfectious pathologies evoluting and requiring antibiotherapy. \nPatients HIV+. \nTransplanted patients or p... | [
{
"id": "NCT00720031_exc_T1",
"type": "Condition",
"text": [
"Cardio-vascular pathologies"
],
"offsets": [
[
0,
27
]
],
"normalized": []
},
{
"id": "NCT00720031_exc_T2",
"type": "Qualifier",
"text": [
"uncontrolled"
],
"offs... | [] | [] | [
{
"id": "NCT00720031_exc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00720031_exc_T9",
"arg2_id": "NCT00720031_exc_T10",
"normalized": []
},
{
"id": "NCT00720031_exc_R2",
"type": "Has_qualifier",
"arg1_id": "NCT00720031_exc_T8",
"arg2_id": "NCT00720031_exc_T11",
"normali... |
NCT00720031_inc | NCT00720031 | [
{
"id": "NCT00720031_inc_text",
"type": "inclusion",
"text": [
"HLA-A2 melanoma patients with : \neither loco-regional or lymph node metastasis \ntransit nodules not surgically resectable \nmeasurable cutaneous or visceral metastasis \nPatients' tumor express Melan-A/MART-1 antigen. \nNo chemother... | [
{
"id": "NCT00720031_inc_T1",
"type": "Condition",
"text": [
"melanoma"
],
"offsets": [
[
7,
15
]
],
"normalized": []
},
{
"id": "NCT00720031_inc_T2",
"type": "Qualifier",
"text": [
"HLA-A2"
],
"offsets": [
[
0... | [] | [] | [
{
"id": "NCT00720031_inc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00720031_inc_T1",
"arg2_id": "NCT00720031_inc_T2",
"normalized": []
},
{
"id": "NCT00720031_inc_R2",
"type": "Has_negation",
"arg1_id": "NCT00720031_inc_T6",
"arg2_id": "NCT00720031_inc_T7",
"normalized... |
NCT00728156_exc | NCT00728156 | [
{
"id": "NCT00728156_exc_text",
"type": "exclusion",
"text": [
"Contraindication to Clopidogrel \nSmoking (current smokers and patients who quit smoking less than six months) \nMalignancy(diagnosed or under investigation) \nHaematological disorders (Anaemia, malignancy, bleeding disorders) \nWomen... | [
{
"id": "NCT00728156_exc_T1",
"type": "Drug",
"text": [
"Clopidogrel"
],
"offsets": [
[
20,
31
]
],
"normalized": []
},
{
"id": "NCT00728156_exc_T2",
"type": "Condition",
"text": [
"Contraindication"
],
"offsets": [
[
... | [] | [] | [
{
"id": "NCT00728156_exc_R1",
"type": "AND",
"arg1_id": "NCT00728156_exc_T2",
"arg2_id": "NCT00728156_exc_T1",
"normalized": []
},
{
"id": "NCT00728156_exc_R2",
"type": "Has_temporal",
"arg1_id": "NCT00728156_exc_T4",
"arg2_id": "NCT00728156_exc_T5",
"normalized": []
},... |
NCT00728156_inc | NCT00728156 | [
{
"id": "NCT00728156_inc_text",
"type": "inclusion",
"text": [
"Patients with T2DM and CAS as defined below: \nClinical definitions \nT2DM: Diagnosed according to the WHO criteria [53]. \nCAD:Presence of any one of the following: Angina plus positive exercise tolerance test, enzyme and/or Q wave p... | [
{
"id": "NCT00728156_inc_T1",
"type": "Condition",
"text": [
"T2DM"
],
"offsets": [
[
14,
18
]
],
"normalized": []
},
{
"id": "NCT00728156_inc_T2",
"type": "Condition",
"text": [
"CAS"
],
"offsets": [
[
23,
... | [] | [] | [
{
"id": "NCT00728156_inc_R1",
"type": "Has_qualifier",
"arg1_id": "NCT00728156_inc_T6",
"arg2_id": "NCT00728156_inc_T7",
"normalized": []
},
{
"id": "NCT00728156_inc_R2",
"type": "Has_value",
"arg1_id": "NCT00728156_inc_T10",
"arg2_id": "NCT00728156_inc_T11",
"normalized"... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.